Van Herk group reports 10.9% ProQR (PRQR) ownership after share issuances

Rhea-AI Filing Summary

ProQR Therapeutics N.V. received an updated ownership filing from Dutch investor Adrianus van Herk and affiliated entities. They report beneficial ownership of 15,384,250 ordinary shares, or about 10.9% of ProQR’s ordinary shares outstanding as of June 26, 2026.

The percentage change is due solely to an increase in ProQR’s total shares outstanding following issuances described in a recent Prospectus Supplement, not from new share purchases or sales by the Van Herk group. The group retains sole or shared voting and dispositive power over the same share amount, and reports no transactions in the past 60 days.

Key Figures

Beneficial ownership: 15,384,250 ordinary shares Ownership percentage: 10.9% Shares outstanding baseline: 141,119,032 ordinary shares +4 more

7 metrics

Beneficial ownership 15,384,250 ordinary shares Aggregate shares held by reporting persons

Ownership percentage 10.9% Portion of ProQR ordinary shares outstanding as of June 26, 2026

Shares outstanding baseline 141,119,032 ordinary shares ProQR shares expected outstanding as of June 26, 2026

Sole voting power (VHI) 15,384,250 shares Ordinary shares over which Van Herk Investments B.V. has sole voting power

Shared voting power (affiliates) 15,384,250 shares Ordinary shares with shared voting power among affiliated entities

Amendment number Amendment No. 6 Sixth amendment to the original Schedule 13D

Event date June 26, 2026 Date of event requiring the amended statement

Key Terms

beneficial ownership, Schedule 13D, Prospectus Supplement, sole voting power, +2 more

6 terms

beneficial ownership financial

"The Reporting Persons hold an aggregate 15,384,250 ordinary shares... representing approximately 10.9% of the ordinary shares outstanding"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Schedule 13D regulatory

"This /A (this "Amendment No. 6") amends the filed on May 28, 2025..."

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

Prospectus Supplement regulatory

"as described in the Issuer's Prospectus Supplement dated June 25, 2026 and filed with the SEC pursuant to Rule 424(b)(5)"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

sole voting power financial

"Number of Shares Beneficially Owned by Each Reporting Person With: | 7 | Sole Voting Power 15,384,250.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

shared dispositive power financial

"Number of Shares Beneficially Owned by Each Reporting Person With: | 10 | Shared Dispositive Power 15,384,250.00"

ordinary shares financial

"Ordinary Shares, nominal value Euro 0.04 per share (Title of Class of Securities)"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/30/2026 - 05:23 PM Accepted by SEC EDGAR 06/30/2026 - 05:23 PM Learn about SEC filing dates

FAQ

How many ProQR (PRQR) shares does the Van Herk group own?

The Van Herk group reports beneficial ownership of 15,384,250 ProQR ordinary shares. This stake is held through multiple Dutch entities and foundations associated with investor Adrianus van Herk, giving the group significant influence but not majority control.

What percentage of ProQR (PRQR) is owned by the Van Herk group?

The Van Herk group holds approximately 10.9% of ProQR’s ordinary shares. This percentage is calculated based on 141,119,032 ordinary shares expected to be outstanding as of June 26, 2026, after share issuances described in a Prospectus Supplement.

Did the Van Herk group buy or sell ProQR (PRQR) shares recently?

The filing states there were no transactions in ProQR ordinary shares by the reporting persons in the past sixty days. The updated ownership percentage results from ProQR increasing its total shares outstanding, not from new buying or selling activity.

Why did the Van Herk group’s ProQR (PRQR) ownership percentage change?

The ownership percentage changed solely because ProQR’s outstanding share count increased following issuances described in a Prospectus Supplement. The Van Herk group’s share count remained at 15,384,250; only the denominator used for the percentage changed.

Who are the reporting entities in the ProQR (PRQR) Schedule 13D/A?

Reporting persons include Van Herk Investments B.V., several affiliated Dutch companies, foundations Penulata and Abchrys, and Adrianus van Herk. The structure reflects layered ownership and management entities through which the ProQR stake is held and controlled.

What share count is used to calculate ProQR (PRQR) ownership percentages?

Percentages are based on 141,119,032 ProQR ordinary shares expected to be issued and outstanding as of June 26, 2026. This figure includes the effects of share issuances described in ProQR’s Prospectus Supplement filed under Rule 424(b)(5).

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 6)

ProQR Therapeutics N.V.

(Name of Issuer)

Ordinary Shares, nominal value Euro 0.04 per share

(Title of Class of Securities)

N71542109

(CUSIP Number)

Van Herk Investments B.V.
Lichtenauerlaan 30,,
The Netherlands, P7, 3062 ME
31-10-241-1555

Evan S. Simpson
1 New Fetter Lane,,
London, X0, EC4A 1AN
44 20 795984-26

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

06/26/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Van Herk Investments B.V.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 15,384,250.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 15,384,250.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of ProQR Therapeutics N.V. (the "Issuer") expected to be issued and outstanding as of June 26, 2026, as described in the Issuer's Prospectus Supplement dated June 25, 2026 and filed with the SEC pursuant to Rule 424(b)(5) on June 26, 2026 (the "Prospectus Supplement") (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Van Herk Investments THI B.V.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Van Herk Private Equity Investments B.V.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Stichting Administratiekantoor Penulata

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Van Herk Management Services B.V.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

A. van Herk Holding B.V.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Stichting Administratiekantoor Abchrys

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

CUSIP Number(s): N71542109

1

Name of reporting person

Adrianus van Herk

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

BK, WC, PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 15,384,250.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 15,384,250.00

11

Aggregate amount beneficially owned by each reporting person

15,384,250.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

10.9 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

* Based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026).

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Ordinary Shares, nominal value Euro 0.04 per share
(b)	Name of Issuer: ProQR Therapeutics N.V.
(c)	Address of Issuer's Principal Executive Offices: Zernikedreef 9, Leiden, NETHERLANDS , 2333 CK.
Item 1 Comment: This Schedule 13D/A (this "Amendment No. 6") amends the Schedule 13D filed on May 28, 2025, as amended by Amendment No. 1 filed on August 20, 2025, Amendment No. 2 filed on September 4, 2025, Amendment No. 3 filed on September 30, 2025, Amendment No. 4 filed on February 6, 2026 and Amendment No. 5 filed on June 3, 2026 (collectively, the "Original Schedule 13D," and as amended and supplemented by this Amendment No. 6, the "Schedule 13D"). Items 1, 2, and 5 of the Original Schedule 13D are hereby amended and supplemented to the extent hereinafter expressly set forth in this Amendment No. 6. Except as amended hereby, the original disclosure set forth in the Original Schedule 13D shall remain unchanged. All capitalized terms used and not expressly defined herein have the respective meanings ascribed to such terms in the Original Schedule 13D.
Item 2.	Identity and Background
(a)	The information previously provided in response to Item 2 is hereby amended and restated by replacing the text thereof in its entirety with the following: This statement is being filed by (i) Van Herk Investments B.V., a private company with limited liability incorporated under the laws of the Netherlands ("VHI"), with respect to Ordinary Shares, nominal value Euro 0.04 per share (the "Ordinary Shares"), beneficially owned by it, (ii) Van Herk Investments THI B.V., a private company with limited liability incorporated under the laws of the Netherlands ("VHIT"), with respect to Ordinary Shares beneficially owned by VHI, (iii) Van Herk Private Equity Investments B.V., a private company with limited liability incorporated under the laws of the Netherlands ("VHPI"), with respect to Ordinary Shares beneficially owned by VHI and VHIT, (iv) Stichting Administratiekantoor Penulata, a foundation organized under the laws of the Netherlands ("Penulata"), with respect to Ordinary Shares beneficially owned by VHI, VHIT and VHPI, (v) Van Herk Management Services B.V., a private company with limited liability incorporated under the laws of the Netherlands ("VHMS"), with respect to Ordinary Shares beneficially owned by VHI, VHIT and VHPI, (vi) Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V., a private company with limited liability incorporated under the laws of the Netherlands ("OGBBA"), with respect to Ordinary Shares beneficially owned by VHI, VHIT, VHPI and VHMS, (vii) A. van Herk Holding B.V., a private company with limited liability incorporated under the laws of the Netherlands ("Holdings"), with respect to Ordinary Shares beneficially owned by VHI, VHIT, VHPI, VHMS and OGBBA, (viii) Stichting Administratiekantoor Abchrys, a foundation organized under the laws of the Netherlands ("Abchrys"), with respect to Ordinary Shares beneficially owned by VHI, VHIT, VHPI, VHMS, OGBBA and Holdings, and (ix) Adrianus van Herk ("Mr. van Herk") with respect to Ordinary Shares beneficially owned by VHI, VHIT, VHPI, VHMS, OGBBA, Holdings, Penulata and Abchrys. Each of Mr. van Herk, VHIT, VHPI, Penulata, VHMS, OGBBA, Holdings and Abchrys disclaims beneficial ownership of the securities covered by this statement.
(b)	The principal business address of each of Mr. van Herk, VHI, VHIT, VHPI, Penulata, VHMS, OGBBA, Holdings and Abchrys is: Lichtenauerlaan 30 3062 ME Rotterdam The Netherlands
(c)	Mr. van Herk is (i) an investor, (ii) the holder of all of the depositary receipts issued by Penulata and Abchrys, (iii) the sole board member of Penulata and Abchrys, and (iv) the sole managing director of VHMS, OGBBA and Holdings. Penulata holds substantially all of the issued and outstanding shares of VHPI. VHPI is the sole shareholder of VHIT. VHIT is the sole shareholder of VHI. VHI is principally engaged in making investments. Abchrys holds substantially all of the issued and outstanding shares of Holdings. Holdings is the sole shareholder of OGBBA. OGBBA is the sole shareholder of VHMS and is principally engaged in making investments. VHMS is the sole managing director of VHI, VHIT and VHPI.
(d)	During the last five years, none of the Reporting Persons, nor, to the knowledge of the Reporting Persons, any of the executive officers or directors of the Reporting Persons, if applicable, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	During the last five years, none of the Reporting Persons, nor, to the knowledge of the Reporting Persons, any of the executive officers or directors of the Reporting Persons, if applicable, has been a party to a civil proceeding of a judicial or administrative body of a competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	Each of VHI, VHIT, VHPI, VHMS, OGBBA and Holdings is a private company with limited liability incorporated under the laws of the Netherlands. Penulata and Abchrys are Netherlands foundations. Mr. van Herk is a citizen of the Netherlands.
Item 5.	Interest in Securities of the Issuer
(a)	The information previously provided in response to Item 5 is hereby amended and restated by replacing the text thereof in its entirety with the following: The information set forth in or incorporated by reference in Items 2, 3, 4 and 6 and on the cover pages of this Schedule 13D is incorporated by reference in its entirety into this Item 5. The Reporting Persons hold an aggregate 15,384,250 ordinary shares, nominal value Euro 0.04 per share, of the Issuer, representing approximately 10.9% of the ordinary shares outstanding as of June 26, 2026. All such ownership percentages of the securities reported herein are based on 141,119,032 ordinary shares, nominal value Euro 0.04 per share, of the Issuer expected to be issued and outstanding as of June 26, 2026, as described in the Prospectus Supplement (after giving effect to the issuances of shares contemplated therein, which the Prospectus Supplement stated were expected to be completed on June 26, 2026). This Amendment No. 6 is being filed to reflect a change in the percentage previously reported solely as a result of the change in the outstanding ordinary shares as a result of the issuances of shares contemplated in the Prospectus Supplement. Except for the change in percentage ownership described herein, there have been no other material changes to the information previously reported since the filing of Amendment No. 5.
(b)	The information set forth in or incorporated by reference in Items 2, 3, 4 and 6 and on the cover pages of this Schedule 13D is incorporated by reference in its entirety into this Item 5.
(c)	Except as set forth in this Schedule 13D, no transactions in Ordinary Shares of the Issuer have been effected during the past sixty days by any of the Reporting Persons.
(d)	Except as set forth herein, to the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any securities of the Issuer beneficially owned by the Reporting Persons as described in this Item 5.
(e)	Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Van Herk Investments B.V.

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Van Herk Investments THI B.V.

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Van Herk Private Equity Investments B.V.

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Stichting Administratiekantoor Penulata

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Van Herk Management Services B.V.

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

A. van Herk Holding B.V.

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Stichting Administratiekantoor Abchrys

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Adrianus van Herk

Signature:	/s/ Erik G.A. Esveld
Name/Title:	Erik G.A. Esveld/Attorney-In-Fact*
Date:	06/30/2026

Comments accompanying signature:

* Pursuant to a Power of Attorney, dated as of September 16, 2019, by and among the Reporting Persons.